M&A Deal Summary |
|
|---|---|
| Date | 2025-12-02 |
| Target | Daramic |
| Sector | Manufacturing |
| Buyer(s) | Kingswood Capital Management |
| Sellers(s) | Asahi Kasei |
| Deal Type | Divestiture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2013 |
| Size | Small |
| Type | Sector Agnostic |
Kingswood Capital Management is an operationally focused private equity firm focused on complex situations throughout North America. The Firm targets control positions in middle-market companies with revenues of $100 to $500 million. Sectors of interest include business services, consumer, retail, energy, industrials, technology, media, communications, and value-added distribution. Kingswood Capital Management was established in 2013 and is based in Los Angeles, California.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 22 |
| Sector: Manufacturing M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 10 of 10 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 19 of 19 |
| Year: 2025 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-10-16 |
Drive DeVilbiss Healthcare
Port Washington, New York, United States Drive DeVilbiss Healthcare manufactures a complete line of medical products, including mobility products, sleep and respiratory products, beds, bariatric products, wheelchairs, sleep surfaces and pressure prevention products, self-assist products, power operated wheelchairs, rehabilitation products, patient room equipment, personal care products and electrotherapy devices. Drive DeVilbiss Healthcare was founded in 2000 and is based in Port Washington, New York. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1922 |
| Sector | Chemicals |
| Employees | 50,352 |
| Revenue | 3.04T JPY (2025) |
Asahi Kasei provides chemicals Segment offers organic and inorganic industrial chemicals, synthetic resin, synthetic rubber, high-compound fertilizer, coating materials, latex, pharmaceutical and food additives, explosives, photopolymers and platemaking systems, separation and ion-exchange membranes, systems, and equipment. Asahi Kasei was incorporated in 1922 and is based in Tokyo, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Manufacturing M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-11-25 |
Veloxis Pharmaceuticals
Cary, North Carolina, United States Veloxis Pharmaceuticals is a fully integrated specialty pharmaceutical company that develops a clinically validated drug-delivery platform for overcoming the deficiencies of drugs with low water solubility, thus improving the bioavailability of marketed drugs and new chemical entities (NCEs). Veloxis Pharmaceuticals is based in Cary, North Carolina. |
Buy | kr.8.9B |
